Table 1.

SALL4 expression and clinicopathological features in 26 choriocarcinoma patients.

Clinical characteristic	Number of patients	SALL4		P value
		Low expression	High expression
Age (year)
<35	10	5	5	0.756
≥35	16	7	9
Risk scores
≤6	11	9	2	0.002
>6	15	3	12
FIGO stages
I	5	5	0	<0.001
II	8	6	2
III–IV	13	1	12
Chemotherapy
No	12	9	3	0.006
Yes	14	3	11